TL;DR: Aetna, a CVS Health company, modified CPB 0362 governing spasticity management, effective February 25, 2026. This coverage policy update expands the list of procedures Aetna deems experimental or investigational — while maintaining surgical coverage for refractory spasticity under strict medical necessity criteria. If your team bills CPT 63185, 63190, 64600–64640, or 64708–64714 for spasticity procedures, here's what changes.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Spasticity Management |
| Policy Code | CPB 0362 |
| Change Type | Modified |
| Effective Date | February 25, 2026 |
| Impact Level | High |
| Specialties Affected | Neurosurgery, neurology, physical medicine & rehabilitation, pain management, pediatrics |
| Key Action | Audit active spasticity claims against the three-part medical necessity criteria before billing CPT 63170, 63185, 63190, 64600–64640, or 64708–64714 |
Aetna Spasticity Management Coverage Criteria and Medical Necessity Requirements 2026
The Aetna spasticity management coverage policy under CPB 0362 Aetna system is a gatekeeper policy. Surgical procedures aren't automatically covered — every claim needs to clear a three-part test before Aetna considers them medically necessary.
Here are the three criteria. Every one must be met:
| # | Covered Indication |
|---|---|
| 1 | The member has good intrinsic lower extremity motor power but is limited in ambulation by spasticity. |
| 2 | The member has the functional capacity and motivation to participate in post-operative rehabilitation. |
| 3 | The member has tried and failed non-surgical medical management — specifically baclofen or other muscle relaxants. |
That third criterion is the one your team will fight about most. "Failed conservative management" needs documentation. Vague chart notes about prior therapy won't clear medical necessity review. You need dates, dosages, duration, and documented failure in the record before you bill CPT 63170 (laminectomy with myelotomy), CPT 63185 or 63190 (laminectomy with rhizotomy), or CPT 63600 (stereotactic spinal cord lesion).
When all three criteria are met, Aetna covers five surgical procedures:
| # | Covered Indication |
|---|---|
| 1 | Longitudinal myelotomy (CPT 63170) |
| 2 | Microsurgical DREZotomy (CPT 63185, 63190) |
| 3 | Percutaneous radiofrequency or thermal rhizotomy (CPT 63600) |
| 4 | Peripheral neurotomy (CPT 64708–64714) |
| 5 | Selective posterior rhizotomy (CPT 63185, 63190) — with age and contraindication restrictions (see below) |
Spasticity management billing for selective posterior rhizotomy has an additional layer. Aetna considers it experimental — not medically necessary — when the member has any of five contraindications. We cover those in the next section.
Prior authorization requirements aren't explicitly detailed in CPB 0362 itself, but neurosurgical procedures at this level virtually always trigger prior auth under Aetna commercial plans. Check your specific plan benefit document. Don't submit claims for CPT 63185 or 63600 without confirming auth status first — a missed PA step is the fastest path to a claim denial on these high-dollar procedures.
The reimbursement exposure here is significant. These are complex surgical procedures. Getting the medical necessity documentation wrong doesn't just affect one claim — it can trigger retrospective audits across your entire spasticity case mix.
Aetna Spasticity Management Exclusions and Non-Covered Indications
This is where CPB 0362 gets detailed — and where most billing teams will face denials if they're not paying attention.
Aetna has designated 20+ specific procedures as experimental, investigational, or unproven for spasticity management. This isn't a catch-all exclusion. Each line item is a specific clinical modality with a specific diagnosis pairing. That matters for billing because many of these procedures have CPT codes that are otherwise billable in other contexts.
Selective posterior rhizotomy contraindications: Aetna flips this procedure from covered to experimental when the member has any of the following:
| # | Excluded Procedure |
|---|---|
| 1 | Concomitant dystonia or rigidity |
| 2 | Profound lower extremity weakness where spasticity assists in standing |
| 3 | Progressive neurological disorders, choreoathetosis, or cerebellar ataxia |
| 4 | Severe basal ganglia damage |
| 5 | Severe fixed joint deformities or scoliosis |
Members ages 2 to 6 are optimal candidates for selective posterior rhizotomy. Outside that window — or with any contraindication present — document carefully before billing.
Procedures designated experimental across all spasticity indications:
The policy explicitly calls out acupuncture (including electro-acupuncture) for post-stroke spasticity. It also excludes dry needling (CPT 20560, 20561) for post-stroke spasticity. These are codes your physical medicine or integrative medicine teams may bill regularly — but not for this indication against Aetna.
Chemo-denervation with alcohol or phenol (CPT 64642–64645) for limb spasticity following spinal cord injury is experimental under this policy. Note the specificity: this exclusion applies to spinal cord injury. Botulinum toxin chemodenervation for other indications isn't addressed the same way — this is a targeted exclusion by mechanism and diagnosis.
Electrical stimulation as an adjunct to botulinum toxin is experimental. If you're billing a combined protocol, the electrical stimulation component won't clear this coverage policy.
Spinal cord stimulation (CPT 63650, 63655, 63661–63664, 63685, 63688) is explicitly non-covered for spasticity. Thalamic stimulation codes (CPT 61863, 61864, 61867, 61868, 61880, 61885, 61886, 61888) are also excluded for spasticity associated with disorders of consciousness following brain damage. These spinal cord stimulator codes get used across multiple diagnoses — make sure your charge capture routes them correctly by indication.
Extracorporeal shock wave therapy (CPT 0101T) is not covered for post-stroke spasticity or spasticity in children with cerebral palsy.
Transcranial magnetic stimulation (CPT 90867) is not covered for spasticity due to multiple sclerosis or other causes.
Cryoneurolysis for spinal cord injury spasticity — experimental. Focal muscle vibration — experimental. Kinesiotaping for lower extremity spasticity — experimental. Pulsed electromagnetic field (PEMF) therapy for cerebral palsy — experimental.
The real issue here is the diagnosis-code pairing. Most of these modality exclusions are diagnosis-specific. A procedure that's covered for one diagnosis can be experimental for another. Your billing guidelines need to reflect that distinction at the ICD-10 level, not just at the CPT level.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Refractory spasticity — surgical management (all 3 criteria met) | Covered | CPT 63170, 63185, 63190, 63600, 64600–64640, 64708–64714 | Must document failed baclofen/muscle relaxant trial |
| Selective posterior rhizotomy, ages 2–6, no contraindications | Covered | CPT 63185, 63190 | Optimal age window per policy |
| Selective posterior rhizotomy with contraindications (dystonia, profound weakness, progressive neurological disease, severe basal ganglia damage, severe joint deformities) | Experimental | CPT 63185, 63190 | Contraindication present = claim denial risk |
| Acupuncture/electro-acupuncture for post-stroke spasticity | Experimental/Not Covered | — | Explicitly excluded |
| Dry needling for post-stroke spasticity | Experimental/Not Covered | CPT 20560, 20561 | Codes billable in other contexts — watch ICD-10 pairing |
| Chemodenervation with alcohol/phenol for spinal cord injury spasticity | Experimental/Not Covered | CPT 64642–64645 | SCI-specific exclusion; other indications differ |
| Electrical stimulation as adjunct to botulinum toxin | Experimental/Not Covered | — | Combined protocols affected |
| Spinal cord stimulation for spasticity | Not Covered | CPT 63650, 63655, 63661–63664, 63685, 63688 | Blanket exclusion for this indication |
| Thalamic stimulation for spasticity with disorders of consciousness | Not Covered | CPT 61863–61868, 61880, 61885, 61886, 61888 | Brain injury indication excluded |
| Extracorporeal shock wave therapy for post-stroke or CP spasticity | Not Covered | CPT 0101T | ESWT excluded for this indication |
| Transcranial magnetic stimulation for spasticity (MS or other) | Not Covered | CPT 90867 | TMS excluded for spasticity indication |
| Cryoneurolysis for SCI spasticity | Experimental | — | SCI-specific |
| PEMF therapy for cerebral palsy spasticity | Experimental | — | CP-specific |
| Tibial nerve neurotomy for spastic equinovarus foot | Experimental | CPT 27325, 27326, 28055 | Specific procedure/indication pairing |
| Surface mechanomyography for elbow spasticity evaluation | Experimental | CPT 0778T | Evaluation method, not treatment |
| Transcranial direct current stimulation for spasticity | Experimental | — | All indications |
Aetna Spasticity Management Billing Guidelines and Action Items 2026
| # | Action Item |
|---|---|
| 1 | Audit your charge capture for CPT 63650, 63655, and 63661–63664 before February 25, 2026. Spinal cord stimulation is explicitly not covered for spasticity under CPB 0362. If your team uses these codes for pain or other covered indications, confirm your ICD-10 codes never pair them with spasticity diagnoses inadvertently. |
| 2 | Verify three-part surgical criteria are documented in the chart before submitting CPT 63170, 63185, 63190, or 63600. Ambulation limitation, rehab capacity, and failed conservative management must all be in the record. The effective date is February 25, 2026 — any claims submitted after that date need to reflect this documentation standard. |
| 3 | Flag CPT 20560 and 20561 (needle insertion/dry needling) for ICD-10 review. These codes are billable for other indications. But billing them against post-stroke spasticity ICD-10 codes will trigger a claim denial under this coverage policy. Your coders need to know the distinction. |
| 4 | Review pediatric spasticity cases for selective posterior rhizotomy eligibility. The policy identifies ages 2–6 as the optimal window. Outside that window, or with any contraindication present, the procedure shifts to experimental. If your practice treats pediatric cerebral palsy patients with CPT 63185 or 63190, confirm age and contraindication status before billing. |
| 5 | Separate chemodenervation billing by mechanism and diagnosis. CPT 64642–64645 for alcohol/phenol chemodenervation is experimental specifically for spinal cord injury spasticity. Botulinum toxin chemodenervation is a different clinical scenario. Make sure your billing team doesn't lump all chemodenervation under one coverage assumption — the distinction matters at the ICD-10 level. |
| 6 | Confirm prior authorization on all neurosurgical spasticity procedures. CPB 0362 doesn't enumerate PA requirements, but laminectomies and rhizotomies at this level virtually always require prior auth under Aetna commercial and managed care plans. Submit PA requests with full documentation of failed conservative management, functional assessment, and rehab candidacy. |
| 7 | Talk to your compliance officer if your practice offers multimodal spasticity protocols. If you combine electrical stimulation with botulinum toxin, or offer PEMF or TMS for spasticity indications, those combinations are excluded. Your documentation practices and billing workflows may need adjustment before the effective date. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Spasticity Management Under CPB 0362
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 63170 | CPT | Laminectomy with myelotomy (e.g., Bischof or DREZ type), cervical, thoracic, or thoracolumbar |
| 63185 | CPT | Laminectomy with rhizotomy; one or two segments |
| 63190 | CPT | Laminectomy with rhizotomy; more than two segments |
| 63600 | CPT | Creation of lesion of spinal cord by stereotactic method, percutaneous, any modality |
| 64600 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64601 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64602 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64603 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64604 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64605 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64606 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64607 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64608 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64609 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64610 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64611 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64612 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64613 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64614 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64615 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64616 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64617 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64618 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64619 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64620 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64621 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64622 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64623 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64624 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64625 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64626 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64627 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64628 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64629 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64630 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64631 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64632 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64633 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64634 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64635 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64636 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64637 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64638 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64639 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64640 | CPT | Destruction by neurolytic agent, somatic nerve |
| 64708 | CPT | Neuroplasty, major peripheral nerve, arm or leg, open |
| 64709 | CPT | Neuroplasty, major peripheral nerve, arm or leg, open |
| 64710 | CPT | Neuroplasty, major peripheral nerve, arm or leg, open |
| 64711 | CPT | Neuroplasty, major peripheral nerve, arm or leg, open |
| 64712 | CPT | Neuroplasty, major peripheral nerve, arm or leg, open |
| 64713 | CPT | Neuroplasty, major peripheral nerve, arm or leg, open |
| 64714 | CPT | Neuroplasty, major peripheral nerve, arm or leg, open |
Not Covered / Experimental CPT Codes
| Code | Type | Description | Reason |
|---|---|---|---|
| 0101T | CPT | Extracorporeal shock wave involving musculoskeletal system, not otherwise specified, high energy | Not covered for post-stroke or cerebral palsy spasticity |
| 0778T | CPT | Surface mechanomyography (sMMG) with concurrent application of inertial measurement unit (IMU) sensors | Experimental for spasticity evaluation |
| 20560 | CPT | Needle insertion(s) without injection(s); 1 or 2 muscle(s) | Experimental for post-stroke spasticity (dry needling) |
| 20561 | CPT | Needle insertion(s) without injection(s); 3 or more muscles | Experimental for post-stroke spasticity (dry needling) |
| 27325 | CPT | Neurectomy, hamstring muscle | Experimental (tibial nerve neurotomy for spastic equinovarus foot) |
| 27326 | CPT | Neurectomy, popliteal (gastrocnemius) | Experimental (tibial nerve neurotomy for spastic equinovarus foot) |
| 28055 | CPT | Neurectomy, intrinsic musculature of foot | Experimental (tibial nerve neurotomy for spastic equinovarus foot) |
| 61863 | CPT | Stereotactic implantation of neurostimulator electrode array, not >2 arrays | Not covered — thalamic stimulation for spasticity with disorders of consciousness |
| 61864 | CPT | Stereotactic implantation of neurostimulator electrode array, each additional | Not covered — thalamic stimulation for spasticity with disorders of consciousness |
| 61867 | CPT | Stereotactic implantation of neurostimulator electrode array, >2 arrays | Not covered — thalamic stimulation for spasticity with disorders of consciousness |
| 61868 | CPT | Stereotactic implantation of neurostimulator electrode array, each additional | Not covered — thalamic stimulation for spasticity with disorders of consciousness |
| 61880 | CPT | Revision or removal of intracranial neurostimulator electrodes | Not covered — thalamic stimulation for spasticity with disorders of consciousness |
| 61885 | CPT | Insertion or replacement of cranial neurostimulator pulse generator or receiver | Not covered — thalamic stimulation for spasticity with disorders of consciousness |
| 61886 | CPT | Insertion or replacement of cranial neurostimulator pulse generator or receiver (multiple arrays) | Not covered — thalamic stimulation for spasticity with disorders of consciousness |
| 61888 | CPT | Revision or removal of cranial neurostimulator pulse generator or receiver | Not covered — thalamic stimulation for spasticity with disorders of consciousness |
| 63650 | CPT | Percutaneous implantation of neurostimulator electrode array, epidural | Not covered for spasticity (spinal cord stimulation exclusion) |
| 63655 | CPT | Laminectomy for implantation of neurostimulator electrodes, plate/paddle, epidural | Not covered for spasticity (spinal cord stimulation exclusion) |
| 63661 | CPT | Removal of spinal neurostimulator electrode percutaneous array(s) | Not covered for spasticity (spinal cord stimulation exclusion) |
| 63662 | CPT | Removal of spinal neurostimulator electrode plate/paddle(s) via laminotomy or laminectomy | Not covered for spasticity (spinal cord stimulation exclusion) |
| 63663 | CPT | Revision including replacement of spinal neurostimulator electrode percutaneous array(s) | Not covered for spasticity (spinal cord stimulation exclusion) |
| 63664 | CPT | Revision including replacement of spinal neurostimulator electrode plate/paddle(s) | Not covered for spasticity (spinal cord stimulation exclusion) |
| 63685 | CPT | Insertion or replacement of spinal neurostimulator pulse generator or receiver | Not covered for spasticity (spinal cord stimulation exclusion) |
| 63688 | CPT | Revision or removal of implanted spinal neurostimulator pulse generator or receiver | Not covered for spasticity (spinal cord stimulation exclusion) |
| 64642 | CPT | Chemodenervation of extremity; 1–4 muscle(s) | Not covered — alcohol/phenol chemodenervation for SCI spasticity |
| 64643 | CPT | Chemodenervation of extremity; each additional extremity, 1–4 muscle(s) | Not covered — alcohol/phenol chemodenervation for SCI spasticity |
| 64644 | CPT | Chemodenervation of extremity; 5 or more muscles | Not covered — alcohol/phenol chemodenervation for SCI spasticity |
| 64645 | CPT | Chemodenervation of extremity; each additional extremity, 5 or more muscles | Not covered — alcohol/phenol chemodenervation for SCI spasticity |
| 90867 | CPT | Therapeutic repetitive transcranial magnetic stimulation (TMS) treatment | Not covered for spasticity due to multiple sclerosis or other causes |
Note: The policy data includes 9 additional CPT codes not fully detailed in the source data extract. Review the full CPB 0362 at app.payerpolicy.org/p/aetna/0362 for the complete code list.
Note: The policy data includes 37 HCPCS codes and 642 ICD-10-CM codes under this policy. The full code sets are available in the PayerPolicy platform with filtering by coverage group.
Get the Full Picture for CPT 63185
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.